title: Toxicity profiles of HER2/neu peptide anticancer vaccines: the picture from Phase/I and II clinical trials.
authors.forename: Constantin N
authors.initials: CN
authors.lastname: Baxevanis
authors.forename: Michael
authors.initials: M
authors.lastname: Papamichail
authors.forename: Sonia A
authors.initials: SA
authors.lastname: Perez
mesh_terms: D019496:Cancer Vaccines / Q000008:administration & dosage / Q000009:adverse effects*; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D005260:Female; D006801:Humans; D008297:Male; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000276:immunology / Q000633:toxicity*; D022223:Vaccines, Subunit / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D019496:Cancer Vaccines; D018719:Erb-b2 Receptor Tyrosine Kinases; D022223:Vaccines, Subunit; C508053:ERBB2 protein, human